Resilience and PRRS in a natural disease challenge model - Dr. Graham Plastow, University of Alberta, from the 2017 North American PRRS/National Swine Improvement Federation Joint Meeting, December 1‐3, 2017, Chicago, Illinois, USA.
More presentations at http://www.swinecast.com/2017-north-american-prrs-nsif-joint-meeting
Dr. Michael Murtaugh and Dr. Cheryl Dvorak - Natural Infection, Immunity & Pr...John Blue
Natural Infection, Immunity & Prevalence of PCV2 - Dr. Michael Murtaugh and Dr. Cheryl Dvorak, University of Minnesota, USA , from the Boehringer Ingelheim Pre-AASV Conference, February 28, 2014 - Dallas, TX
More presentations at http://www.swinecast.com/2014-boehringer-ingelheim-aasv
Dr. Michael Murtaugh and Dr. Cheryl Dvorak - Natural Infection, Immunity & Pr...John Blue
Natural Infection, Immunity & Prevalence of PCV2 - Dr. Michael Murtaugh and Dr. Cheryl Dvorak, University of Minnesota, USA , from the Boehringer Ingelheim Pre-AASV Conference, February 28, 2014 - Dallas, TX
More presentations at http://www.swinecast.com/2014-boehringer-ingelheim-aasv
La disponibilidad de un sistema de multiplicación del virus de la hepatitis C (VHC) infeccioso en cultivos celulares está permitiendo investigar nuevos factores de respuesta a tratamientos antivíricos en condiciones controladas. Se presentará evidencia de que el fitness vírico puede ser un factor de multiresistencia a inhibidores y quese pueden obtener eficientes reducciones de carga viral empleando diseños secuenciales de administración de inhibidores que incluyan ribavirina. Se discutirán posibilidades de aplicación clínica.
This presents a number of case studies on the application on high-throughput sequencing (HTS), next generation sequencing (NGS), to biological problems ranging from human genome sequencing, identification of disease mutations, metagenomics, virus discovery, epidemic, transmission chains and viral populations. Presented at the University of Glasgow on Friday 26th June 2015.
New technologies for manufacturing recombinant products in embryonated eggsEluemuno R Blyden
New non-GMO vector technologies for expressing recombinant proteins in hen eggs offer a novel development and production platform for biologics and vaccines. By upgrading egg-based manufacturing, these technologies bring a wealth of experience and resources to the 21st Century fight against emerging diseases. The AdCEV(TM) vector technology developed by AfriVax and the Sendai Virus vector technologies can potentially improve manufacturing in eggs by increasing yields, expanding the repertoire of possible products, and increasing biosafety. With AdCEV(TM) technology, eggs can be used as miniature bioreactors for rapidly manufacturing a wide range of high-value biopharmaceuticals. The speed with which recombinant products can be developed, scaled and manufactured with these technologies offers a unique competitive advantage compared to other industrial technologies like cell culture and plants.
Male urogenital tract infection is one of the most important
causes of male infertility, worldwide since genital tract
infection and inflammation have been associated with 8-35%
of male infertility cases. Bacteriospermia is defined as the
presence of bacteria in seminal fluid samples.
Bacteriospermia may play a major role in infertility. Male
accessory sex glands infection is a major risk factor in
infertility. The significance of pathophysiology of
bacteriospermia has been seriously discussed in recent years.The isolation of microorganisms from seminal fluid especially of infertile men had been widely reported. It is always recommended that microbiological study of semen can be performed in asymptomatic infertile men with leukocyto-spermia. Aerobic and anaerobic culture of semen can detect a wide range of urogenital pathogens.
Disease State Plasma Newsflash - August 2014 - BBI SolutionsBBISolutions
In this month’s newsflash view our latest inventory of autoimmune, infectious disease and ethically approved disease state plasma units. You can also find out about our ethics approval scheme and our speciality blood products.
Dr. Jack Dekkers and Dr. Bob Rowland - Introduction of the ProgramJohn Blue
Introduction of the Program - Dr. Jack Dekkers,Iowa State University, and Dr. Bob Rowland, Kansas State University, from the 2017 North American PRRS/National Swine Improvement Federation Joint Meeting, December 1‐3, 2017, Chicago, Illinois, USA.
More presentations at http://www.swinecast.com/2017-north-american-prrs-nsif-joint-meeting
Dr. Jack Dekkers - Using genetic selection and genomics to combat infectious ...John Blue
Using genetic selection and genomics to combat infectious disease - Dr. Jack Dekkers, Iowa State University, from the 2017 North American PRRS/National Swine Improvement Federation Joint Meeting, December 1‐3, 2017, Chicago, Illinois, USA.
More presentations at http://www.swinecast.com/2017-north-american-prrs-nsif-joint-meeting
La disponibilidad de un sistema de multiplicación del virus de la hepatitis C (VHC) infeccioso en cultivos celulares está permitiendo investigar nuevos factores de respuesta a tratamientos antivíricos en condiciones controladas. Se presentará evidencia de que el fitness vírico puede ser un factor de multiresistencia a inhibidores y quese pueden obtener eficientes reducciones de carga viral empleando diseños secuenciales de administración de inhibidores que incluyan ribavirina. Se discutirán posibilidades de aplicación clínica.
This presents a number of case studies on the application on high-throughput sequencing (HTS), next generation sequencing (NGS), to biological problems ranging from human genome sequencing, identification of disease mutations, metagenomics, virus discovery, epidemic, transmission chains and viral populations. Presented at the University of Glasgow on Friday 26th June 2015.
New technologies for manufacturing recombinant products in embryonated eggsEluemuno R Blyden
New non-GMO vector technologies for expressing recombinant proteins in hen eggs offer a novel development and production platform for biologics and vaccines. By upgrading egg-based manufacturing, these technologies bring a wealth of experience and resources to the 21st Century fight against emerging diseases. The AdCEV(TM) vector technology developed by AfriVax and the Sendai Virus vector technologies can potentially improve manufacturing in eggs by increasing yields, expanding the repertoire of possible products, and increasing biosafety. With AdCEV(TM) technology, eggs can be used as miniature bioreactors for rapidly manufacturing a wide range of high-value biopharmaceuticals. The speed with which recombinant products can be developed, scaled and manufactured with these technologies offers a unique competitive advantage compared to other industrial technologies like cell culture and plants.
Male urogenital tract infection is one of the most important
causes of male infertility, worldwide since genital tract
infection and inflammation have been associated with 8-35%
of male infertility cases. Bacteriospermia is defined as the
presence of bacteria in seminal fluid samples.
Bacteriospermia may play a major role in infertility. Male
accessory sex glands infection is a major risk factor in
infertility. The significance of pathophysiology of
bacteriospermia has been seriously discussed in recent years.The isolation of microorganisms from seminal fluid especially of infertile men had been widely reported. It is always recommended that microbiological study of semen can be performed in asymptomatic infertile men with leukocyto-spermia. Aerobic and anaerobic culture of semen can detect a wide range of urogenital pathogens.
Disease State Plasma Newsflash - August 2014 - BBI SolutionsBBISolutions
In this month’s newsflash view our latest inventory of autoimmune, infectious disease and ethically approved disease state plasma units. You can also find out about our ethics approval scheme and our speciality blood products.
Dr. Jack Dekkers and Dr. Bob Rowland - Introduction of the ProgramJohn Blue
Introduction of the Program - Dr. Jack Dekkers,Iowa State University, and Dr. Bob Rowland, Kansas State University, from the 2017 North American PRRS/National Swine Improvement Federation Joint Meeting, December 1‐3, 2017, Chicago, Illinois, USA.
More presentations at http://www.swinecast.com/2017-north-american-prrs-nsif-joint-meeting
Dr. Jack Dekkers - Using genetic selection and genomics to combat infectious ...John Blue
Using genetic selection and genomics to combat infectious disease - Dr. Jack Dekkers, Iowa State University, from the 2017 North American PRRS/National Swine Improvement Federation Joint Meeting, December 1‐3, 2017, Chicago, Illinois, USA.
More presentations at http://www.swinecast.com/2017-north-american-prrs-nsif-joint-meeting
Dr. Jack Dekkers - Genetics of Host Resistance to PRRS and PCV2John Blue
Genetics of Host Resistance to PRRS and PCV2 - Dr. Jack Dekkers, Iowa State University, from the 2015 North American PRRS Symposium, December 4 - 5, 2015, Chicago, IL, USA.
More presentations at http://www.swinecast.com/2015-north-american-prrs-symposium
Dr. Andrea Wilson - New PRRS disease phenotypes as vaccine and genetic improv...John Blue
New PRRS disease phenotypes as vaccine and genetic improvement targets - Dr. Andrea Wilson, Roslin Institute, from the 2017 North American PRRS/National Swine Improvement Federation Joint Meeting, December 1‐3, 2017, Chicago, Illinois, USA.
More presentations at http://www.swinecast.com/2017-north-american-prrs-nsif-joint-meeting
This presentation covers a brief introduction to Diagnostic kit with its different types and examples. Also, this presentation covers examples of some common diseases with their diagnostic test.
A Vaccine Approach against HIV-1, Manufacturing Env proteins: from Bench to B...KBI Biopharma
A Vaccine Approach against HIV-1, Manufacturing Env proteins: from Bench to Bedside
Abhinav A.Shukla, Ph.D. Senior Vice President, Process Development & Manufacturing, KBI Biopharma
Prof.Barton Haynes,M.D.Director,Duke Human Vaccine Institute
Dr. Jay Calvert - Vaccination Against a Recently Emerged Virulent PRRS Virus ...John Blue
Vaccination Against a Recently Emerged Virulent PRRS Virus (RFLP 1-7-4) - Dr. Jay Calvert, Associate Research Fellow at Zoetis, from the 2015 North American PRRS Symposium, December 4 - 5, 2015, Chicago, IL, USA.
More presentations at http://www.swinecast.com/2015-north-american-prrs-symposium
Dr. Rebecca Pentecost addresses Pennsylvania Llama and Alpaca Association\'s Annual Meeting at Toftrees Golf and Convention Center, State College, PA on March 24, 2011.
Dr. Sid Thakur - Antimicrobial Resistance: Do We Know Everything?John Blue
Antimicrobial Resistance: Do We Know Everything? - Dr. Sid Thakur, Assistant Professor, North Carolina State University, from the 2013 NIAA Merging Values and Technology conference, April 15-17, 2013, Louisville, KY, USA.
More presentations at http://www.trufflemedia.com/agmedia/conference/2013-niaa-merging-values-and-technology
Dr. Jack Dekkers - Update on the host genetics of resistance to porcine diseasesJohn Blue
Update on the host genetics of resistance to porcine diseases - Dr. Jack Dekkers, Animal Breeding and Genetics, Department of Animal Science, Iowa State University, from the 2016 North American PRRS Symposium, December 3‐4, 2016, Chicago, Illinois, USA.
More presentations at http://www.swinecast.com/2016-north-american-prrs-symposium
Robert P. Edwards, MD, Chair of OB/GYN/RS, Co-Director of Women's Cancer Program at University of Pittsburgh, offers information about the current state of immunotherapy for recurrent ovarian cancer patients.
Advances and Applications Enabled by Single Cell TechnologyQIAGEN
Over the past 5 years, single-cell genomics have become a powerful technology for studying small samples and rare cells, and for dissecting complex populations such as heterogeneous tumors. Single-cell technology is enabling many new insights into diverse research areas from oncology, immunology and microbiology to neuroscience, stem cell and developmental biology. This webinar introduces single-cell technology and summarizes the newest scientific applications in various research areas, all in the context of current literature.
Dr. Randall Prather - PRRS Resistant PigsJohn Blue
PRRS Resistant Pigs - Dr. Randall Prather, University of Missouri-Columbia, from the 2016 Missouri Pork Expo, February 9-10, 2016, Columbia, Missouri, USA.
More presentations at http://www.swinecast.com/2016-missouri-pork-expo
Similar to Dr. Graham Plastow - Resilience and PRRS in a natural disease challenge model (20)
Jordan Hoewischer - OACI Farmer Certification ProgramJohn Blue
OACI Farmer Certification Program - Jordan Hoewischer, Ohio Farm Bureau, from the 2020 Conservation Tillage and Technology Conference, held March 3-4, 2020, Ada, OH, USA.
Fred Yoder - No-till and Climate Change: Fact, Fiction, and IgnoranceJohn Blue
No-till and Climate Change: Fact, Fiction, and Ignorance - Fred Yoder, Former President, National Corn Growers Association, from the 2020 Conservation Tillage and Technology Conference, held March 3-4, 2020, Ada, OH, USA.
Dr. John Grove - Fifty Years Of No-till Research In KentuckyJohn Blue
Fifty Years Of No-till Research In Kentucky - Dr. John Grove, Univerity of Kentucky, from the 2020 Conservation Tillage and Technology Conference, held March 3-4, 2020, Ada, OH, USA.
Dr. Warren Dick - Pioneering No-till Research Since 1962John Blue
Pioneering No-till Research Since 1962 - Dr. Warren Dick, OSU-OARDC (retired), from the 2020 Conservation Tillage and Technology Conference, held March 3-4, 2020, Ada, OH, USA.
Dr. Christine Sprunger - The role that roots play in building soil organic ma...John Blue
The role that roots play in building soil organic matter and soil health - Dr. Christine Sprunger, OSU - SENR, from the 2020 Conservation Tillage and Technology Conference, held March 3-4, 2020, Ada, OH, USA.
Dr. Leonardo Deiss - Stratification, the Role of Roots, and Yield Trends afte...John Blue
Stratification, the Role of Roots, and Yield Trends after 60 years of No-till - Dr. Leonardo Deiss, OSU, from the 2020 Conservation Tillage and Technology Conference, held March 3-4, 2020, Ada, OH, USA.
Dr. Steve Culman - No-Till Yield Data AnalysisJohn Blue
No-Till Yield Data Analysis - Dr. Steve Culman, OSU Soil Fertility Extension Specialist, from the 2020 Conservation Tillage and Technology Conference, held March 3-4, 2020, Ada, OH, USA.
Alan Sundermeier and Dr. Vinayak Shedekar - Soil biological Response to BMPs John Blue
Soil biological Response to BMPs - Alan Sundermeier, OSU Extension, and Dr. Vinayak Shedekar, USDA-ARS, from the 2020 Conservation Tillage and Technology Conference, held March 3-4, 2020, Ada, OH, USA.
Dr. Curtis Young - Attracting And Protecting PollinatorsJohn Blue
Attracting And Protecting Pollinators - Dr. Curtis Young, OSU Extension, from the 2020 Conservation Tillage and Technology Conference, held March 3-4, 2020, Ada, OH, USA.
Sarah Noggle - Cover Crop Decision Tool SelectorJohn Blue
Cover Crop Decision Tool Selector - Sarah Noggle, OSU Extension, from the 2020 Conservation Tillage and Technology Conference, held March 3-4, 2020, Ada, OH, USA.
Hemp Regulations - Jim Belt, ODA, Head of Hemp for Ohio, from the 2020 Conservation Tillage and Technology Conference, held March 3-4, 2020, Ada, OH, USA.
John Barker - UAVs: Where Are We And What's NextJohn Blue
UAVs: Where Are We And What's Next - John Barker, OSU Extension, from the 2020 Conservation Tillage and Technology Conference, held March 3-4, 2020, Ada, OH, USA.
Dr. Rajbir Bajwa - Medical uses of MarijuanaJohn Blue
Medical uses of Marijuana - Dr. Rajbir Bajwa, Coordinator of legal medical marijuana sales, from the 2020 Conservation Tillage and Technology Conference, held March 3-4, 2020, Ada, OH, USA.
Dr. Jeff Stachler - Setting up a Corn and Soybean Herbicide Program with Cove...John Blue
Setting up a Corn and Soybean Herbicide Program with Cover Crops - Dr. Jeff Stachler, OSU Extension, from the 2020 Conservation Tillage and Technology Conference, held March 3-4, 2020, Ada, OH, USA.
Dr. Chad Penn - Developing A New Approach To Soil Phosphorus Testing And Reco...John Blue
Developing A New Approach To Soil Phosphorus Testing And Recommendations - Dr. Chad Penn, USDA-ARS, from the 2020 Conservation Tillage and Technology Conference, held March 3-4, 2020, Ada, OH, USA.
Jim Hoorman - Dealing with Cover Crops after Preventative PlantingJohn Blue
Dealing with Cover Crops after Preventative Planting - Jim Hoorman, Hoorman Soil Health Services, from the 2020 Conservation Tillage and Technology Conference, held March 3-4, 2020, Ada, OH, USA.
Dr. Sjoerd Duiker - Dealing with Poor Soil Structure and Soil Compaction John Blue
Dealing with Poor Soil Structure and Soil Compaction - Dr. Sjoerd Duiker, Extension Agronomist, Penn State University, from the 2020 Conservation Tillage and Technology Conference, held March 3-4, 2020, Ada, OH, USA.
Christine Brown - Canadian Livestock Producers Efforts to Improve Water QualityJohn Blue
Canadian Livestock Producers Efforts to Improve Water Quality - Christine Brown, Ontario Ministry of Agriculture, from the 2020 Conservation Tillage and Technology Conference, held March 3-4, 2020, Ada, OH, USA.
Dr. Lee Briese - Details Matter (includes details about soil, equipment, cove...John Blue
Details Matter (includes details about soil, equipment, cover crops...) - Dr. Lee Briese, North Dakota, 2017 International Crop Adviser of the Year, from the 2020 Conservation Tillage and Technology Conference, held March 3-4, 2020, Ada, OH, USA.
Nutraceutical market, scope and growth: Herbal drug technologyLokesh Patil
As consumer awareness of health and wellness rises, the nutraceutical market—which includes goods like functional meals, drinks, and dietary supplements that provide health advantages beyond basic nutrition—is growing significantly. As healthcare expenses rise, the population ages, and people want natural and preventative health solutions more and more, this industry is increasing quickly. Further driving market expansion are product formulation innovations and the use of cutting-edge technology for customized nutrition. With its worldwide reach, the nutraceutical industry is expected to keep growing and provide significant chances for research and investment in a number of categories, including vitamins, minerals, probiotics, and herbal supplements.
Seminar of U.V. Spectroscopy by SAMIR PANDASAMIR PANDA
Spectroscopy is a branch of science dealing the study of interaction of electromagnetic radiation with matter.
Ultraviolet-visible spectroscopy refers to absorption spectroscopy or reflect spectroscopy in the UV-VIS spectral region.
Ultraviolet-visible spectroscopy is an analytical method that can measure the amount of light received by the analyte.
Deep Behavioral Phenotyping in Systems Neuroscience for Functional Atlasing a...Ana Luísa Pinho
Functional Magnetic Resonance Imaging (fMRI) provides means to characterize brain activations in response to behavior. However, cognitive neuroscience has been limited to group-level effects referring to the performance of specific tasks. To obtain the functional profile of elementary cognitive mechanisms, the combination of brain responses to many tasks is required. Yet, to date, both structural atlases and parcellation-based activations do not fully account for cognitive function and still present several limitations. Further, they do not adapt overall to individual characteristics. In this talk, I will give an account of deep-behavioral phenotyping strategies, namely data-driven methods in large task-fMRI datasets, to optimize functional brain-data collection and improve inference of effects-of-interest related to mental processes. Key to this approach is the employment of fast multi-functional paradigms rich on features that can be well parametrized and, consequently, facilitate the creation of psycho-physiological constructs to be modelled with imaging data. Particular emphasis will be given to music stimuli when studying high-order cognitive mechanisms, due to their ecological nature and quality to enable complex behavior compounded by discrete entities. I will also discuss how deep-behavioral phenotyping and individualized models applied to neuroimaging data can better account for the subject-specific organization of domain-general cognitive systems in the human brain. Finally, the accumulation of functional brain signatures brings the possibility to clarify relationships among tasks and create a univocal link between brain systems and mental functions through: (1) the development of ontologies proposing an organization of cognitive processes; and (2) brain-network taxonomies describing functional specialization. To this end, tools to improve commensurability in cognitive science are necessary, such as public repositories, ontology-based platforms and automated meta-analysis tools. I will thus discuss some brain-atlasing resources currently under development, and their applicability in cognitive as well as clinical neuroscience.
Richard's entangled aventures in wonderlandRichard Gill
Since the loophole-free Bell experiments of 2020 and the Nobel prizes in physics of 2022, critics of Bell's work have retreated to the fortress of super-determinism. Now, super-determinism is a derogatory word - it just means "determinism". Palmer, Hance and Hossenfelder argue that quantum mechanics and determinism are not incompatible, using a sophisticated mathematical construction based on a subtle thinning of allowed states and measurements in quantum mechanics, such that what is left appears to make Bell's argument fail, without altering the empirical predictions of quantum mechanics. I think however that it is a smoke screen, and the slogan "lost in math" comes to my mind. I will discuss some other recent disproofs of Bell's theorem using the language of causality based on causal graphs. Causal thinking is also central to law and justice. I will mention surprising connections to my work on serial killer nurse cases, in particular the Dutch case of Lucia de Berk and the current UK case of Lucy Letby.
Richard's aventures in two entangled wonderlandsRichard Gill
Since the loophole-free Bell experiments of 2020 and the Nobel prizes in physics of 2022, critics of Bell's work have retreated to the fortress of super-determinism. Now, super-determinism is a derogatory word - it just means "determinism". Palmer, Hance and Hossenfelder argue that quantum mechanics and determinism are not incompatible, using a sophisticated mathematical construction based on a subtle thinning of allowed states and measurements in quantum mechanics, such that what is left appears to make Bell's argument fail, without altering the empirical predictions of quantum mechanics. I think however that it is a smoke screen, and the slogan "lost in math" comes to my mind. I will discuss some other recent disproofs of Bell's theorem using the language of causality based on causal graphs. Causal thinking is also central to law and justice. I will mention surprising connections to my work on serial killer nurse cases, in particular the Dutch case of Lucia de Berk and the current UK case of Lucy Letby.
Observation of Io’s Resurfacing via Plume Deposition Using Ground-based Adapt...Sérgio Sacani
Since volcanic activity was first discovered on Io from Voyager images in 1979, changes
on Io’s surface have been monitored from both spacecraft and ground-based telescopes.
Here, we present the highest spatial resolution images of Io ever obtained from a groundbased telescope. These images, acquired by the SHARK-VIS instrument on the Large
Binocular Telescope, show evidence of a major resurfacing event on Io’s trailing hemisphere. When compared to the most recent spacecraft images, the SHARK-VIS images
show that a plume deposit from a powerful eruption at Pillan Patera has covered part
of the long-lived Pele plume deposit. Although this type of resurfacing event may be common on Io, few have been detected due to the rarity of spacecraft visits and the previously low spatial resolution available from Earth-based telescopes. The SHARK-VIS instrument ushers in a new era of high resolution imaging of Io’s surface using adaptive
optics at visible wavelengths.
Introduction:
RNA interference (RNAi) or Post-Transcriptional Gene Silencing (PTGS) is an important biological process for modulating eukaryotic gene expression.
It is highly conserved process of posttranscriptional gene silencing by which double stranded RNA (dsRNA) causes sequence-specific degradation of mRNA sequences.
dsRNA-induced gene silencing (RNAi) is reported in a wide range of eukaryotes ranging from worms, insects, mammals and plants.
This process mediates resistance to both endogenous parasitic and exogenous pathogenic nucleic acids, and regulates the expression of protein-coding genes.
What are small ncRNAs?
micro RNA (miRNA)
short interfering RNA (siRNA)
Properties of small non-coding RNA:
Involved in silencing mRNA transcripts.
Called “small” because they are usually only about 21-24 nucleotides long.
Synthesized by first cutting up longer precursor sequences (like the 61nt one that Lee discovered).
Silence an mRNA by base pairing with some sequence on the mRNA.
Discovery of siRNA?
The first small RNA:
In 1993 Rosalind Lee (Victor Ambros lab) was studying a non- coding gene in C. elegans, lin-4, that was involved in silencing of another gene, lin-14, at the appropriate time in the
development of the worm C. elegans.
Two small transcripts of lin-4 (22nt and 61nt) were found to be complementary to a sequence in the 3' UTR of lin-14.
Because lin-4 encoded no protein, she deduced that it must be these transcripts that are causing the silencing by RNA-RNA interactions.
Types of RNAi ( non coding RNA)
MiRNA
Length (23-25 nt)
Trans acting
Binds with target MRNA in mismatch
Translation inhibition
Si RNA
Length 21 nt.
Cis acting
Bind with target Mrna in perfect complementary sequence
Piwi-RNA
Length ; 25 to 36 nt.
Expressed in Germ Cells
Regulates trnasposomes activity
MECHANISM OF RNAI:
First the double-stranded RNA teams up with a protein complex named Dicer, which cuts the long RNA into short pieces.
Then another protein complex called RISC (RNA-induced silencing complex) discards one of the two RNA strands.
The RISC-docked, single-stranded RNA then pairs with the homologous mRNA and destroys it.
THE RISC COMPLEX:
RISC is large(>500kD) RNA multi- protein Binding complex which triggers MRNA degradation in response to MRNA
Unwinding of double stranded Si RNA by ATP independent Helicase
Active component of RISC is Ago proteins( ENDONUCLEASE) which cleave target MRNA.
DICER: endonuclease (RNase Family III)
Argonaute: Central Component of the RNA-Induced Silencing Complex (RISC)
One strand of the dsRNA produced by Dicer is retained in the RISC complex in association with Argonaute
ARGONAUTE PROTEIN :
1.PAZ(PIWI/Argonaute/ Zwille)- Recognition of target MRNA
2.PIWI (p-element induced wimpy Testis)- breaks Phosphodiester bond of mRNA.)RNAse H activity.
MiRNA:
The Double-stranded RNAs are naturally produced in eukaryotic cells during development, and they have a key role in regulating gene expression .
Dr. Graham Plastow - Resilience and PRRS in a natural disease challenge model
1. Resilience and PRRS in a natural
disease challenge model
Graham Plastow
University of Alberta
Chicago, December 2nd 2017
2. Application of Genomics to Improve
Disease Resilience and Sustainability
in Pork Production
Project Leaders: Michael Dyck (U Alberta), John Harding
(U Saskatchewan), Bob Kemp (PigGen Canada)
3. Application of Genomics to Improve
Disease Resilience and Sustainability
in Pork Production
Project Leaders: Michael Dyck (U Alberta), John Harding
(U Saskatchewan), Bob Kemp (PigGen Canada)
Includes several components
Vaccine response
Salmonella challenge (Ab/Microbiome)
Nutrition & Gut Health (Microbiome)
PRRSV Pregnant Gilt Challenge e.g. Vet. Micro. 209: 114-123 (2017)
Organoid models
and Natural Challenge Model
4. A Natural Challenge Model
for Disease Resilience in Pigs
Jack Dekkers, John Harding, Frederic Fortin, PigGen
Canada, Michael Dyck, Graham Plastow
Andrea Wilson, Bonnie Mallard, Claire Rogel-Gaillard,
Ben Willing, Catherine Field
Austin Putz, Jiehan Lim, Ziqi Yang
5. What is Resilience?
• Definition of Resilience…..
– “the capacity to recover quickly from difficulties;
toughness.” Oxford Dictionary https://en.oxforddictionaries.com
• Disease Resilience…..
– combination of resistance and tolerance to
diseases….animal’s ability to remain productive
despite being disease-challenged
– The ability of pigs to respond to pathogens in
a way that minimizes the impact of disease
6. •Objectives
1. Establish a natural challenge model for grow-finish pigs
2. Determine the genetic basis of disease resilience in pigs
3. Develop predictors of resilience that can be obtained at a
young age in a high-health bio-secure environment
A Natural Challenge Model
for Disease Resilience in Pigs
7. • PRRS is the most significant disease but it is not only
PRRSV
• Numerous other pathogens are commonly isolated along
with PRRS virus from affected nursery or finishing pigs.
Other bacteria such as Streptococcus suis, Escherichia
coli, Salmonella cholerasuis, Haemophilus parasuis,
and Mycoplasma hyopneumoniae have been reported, as
well as viruses such as porcine respiratory coronavirus
and swine influenza virus.
Dee, Merck Veterinary Manual,
http://www.merckvetmanual.com/generalized-conditions/porcine-reproductive-and-
respiratory-syndrome/overview-of-porcine-reproductive-and-respiratory-syndrome
Motivation?
8. Health is the Biggest Opportunity for
Animal Genomics
zoonoses (60% of EIDs)
Adapted from a slide by Dan Barreda The British Pig Association
http://www.britishpigs.org.uk/modern2.htm
10. • Established by introducing selected “seeder pigs” from
different commercial farms with first few batches
entering the model
• Continuous flow
• Each batch from a single company/herd
• All are LW*LR barrows from high health herds
• Weaned and transported to acclimation unit where
samples are collected prior to challenge
Natural Challenge (Pig & Sample Flow)
11. 60-75 LW/LR barrows/batch High
Health Multiplier Farm weaned - 21
days old
transported
Nursery 1 (2 weeks)
Quarantine and acclimatization
CDPQ Test Station (4 weeks)
Nursery
CDPQ Test Station (16 weeks)
Grower & finisher
transferred
Severity of disease challenge
Clean
Mild
challenge
Severe
challenge
Natural Challenge (Pig & Sample Flow)
Blood 1 – 26 day-old
Blood 3 – 56 days
(Week 2 post-exposure)
Blood 4 – 84 days
(Week 6 post-exposure)
Exposure to seeder
pigs at 42 days
DNA Samples -
Genotyping
660,000 SNPs
Target 3,300
pigs
12. N Cook, Alberta Agriculture & Forestry, Lacombe
J-P Laforest, Université Laval F Fortin, CDPQ, QC
13. Natural Challenge (Pig & Sample Flow)
60-75 barrows/batch from
High Health Multiplier Farm
Weaned at 21 days old
transported
CRSAD Building
(3 weeks)
Nursery I
D26 – Blood 1
D42 – Blood 2 &
exit Nursery I
CDPQ Test Station
(4 weeks)
Nursery II
D56 – Blood 3
CDPQ Test Station (16 weeks)
Grower & Finisher
D86 – Blood 4
D120B1-8/D166B9-on – Blood 5
transferred
Blood Samples collected
1 HIR, DRAA, CBC, WBT, Serology
2 HIR, Serology, microbiome
3 CBC, Nab, IgG, WBT, microbiome
4
CBC, IgG, WBT, Serology,
microbiome
5 Serology
6 WBT, Serology (sick & healthy)
14. Overview - Data
Quarantine
Nursery
Immune Response
•HIR
•DRAA
•CBC
•Blood Stimulation
•Phagocytosis
Blood Transcriptome
Blood Metabolome
Blood Proteome
Gut Microbiome
Natural
Challenge
Facility
Growth
Feed/ Water Intake
Mortality/Morbidity
Carcass/Ultrasound
Disease Diagnostics
Blood Transcriptome
Gut Microbiome
March 14, 2017 Midwest 2017 14
Deliverables
Phenotypic
Prediction
of
Resilience
Genetic
Prediction
of
Resilience
Trait:
• Parameters
• Architecture
• Mechanisms
Integrated statistical and
bioinformatic analyses
Putz, A.M., Harding, J.C.S., Fortin, F.,
Plastow, G., Dekkers, J.C.M. (2017) A
natural challenge model for disease
resilience in wean-to-finish pigs. ASAS
MidWest Meeting March 2017. J.
Anim. Sci 95: supplement2, p.17.
Sample
bank
16. Lung lesion (Mycoplasma
hyopneumoniae, complicated
with PRRS & Streptococcus
suis)
Lung lesion
(chronic stage of
PRRS in grower)
Lung lesion (Haemophilus
parasuis in grower)
Types of lung lesion found in dead pigs with respiratory signs
NATURAL CHALLENGE
Jiehan Lim
17. Mortality Reasons %
Lameness 10
Coughing 11
Unthrifty 5
Diarrhea red 1
grey/brown 19
yellow 7
Dermatitis 4
CNS 3
Respiratory 31
Arthritis 5
Inappetance 2
Cyanosis 2
Example Growth Curves
# health
treatments
Blood
1
Blood
3
Blood
4
Disease exposure
Average Mortality at
78 ± 2.3 days
18. Predicting which Pigs are Resilient ?
Immune Response Measures
• Complete Blood Counts (UAlberta)
‒ CBC = Evaluates white blood cells, leukocytes, B cells,
monocytes and acute phase proteins in pigs
• High Immune Response Assay (UGuelph)
‒ HIR = Assesses adaptive immune response in pigs including:
antibody-mediated and cell-mediated immune responses
• Disease Resistance Assay for Animals (ULaval; USask)
‒ DRAA = Assess immune competence in pigs based on
proliferation of peripheral blood mononuclear cells in pigs
after stimulation by mitogens
‒ Total Immunoglobulin (IgG) & Natural antibodies (NAb) ELISA
• Blood Transcriptome (UAlberta)
22. Daily Fluctuation in FI as a Measure of Resilience
Austin Putz
Trait
rg with
MSE of FI
Growth Finish -0.31 + 0.27
# Treatments 0.56 + 0.20
Mortality Liability 0.54 + 0.36
MSE of FI
h2 = 0.22+ 0.07
23. • A natural challenge model for characterization of
disease resilience in pigs has been successfully
established
Conclusions 1
• MSE of FI shows promise as a measure of
resilience.
• Heritable variation in growth, feed intake curves, mortality,
morbidity
24. 3300 YXLR WEANER PIGS
FROM HIGH-HEALTH HERDS
BATCHES OF 60-75 PIGS/3 WEEKS
650K SNP
genotypes
Trait Genetics
• Parameters
• Architecture
• Mechanisms
Genetic
Prediction
of Resilience
Phenotypic
Prediction
of Resilience
PROJECT
DELIVE-
RABLES
Potential BIOMARKERS
collected on
young healthy pigs
Immune Response
• High Immune Response
• In vitro immune tests
• Phagocytosis tests
Blood Transcriptome
Blood Metabolome
Blood Proteome
Gut Microbiome
Integrated
statistical and
bioinformatic
analyses
NATURAL CHALLENGE FACILITYQUARANTINE NURSERY
Continuous flow RESILIENCE PHENOTYPES
Mortality/Morbidity
Growth performance
Feed intake
Water intake
Disease diagnostics
Blood transcriptome
Gut Microbiome
Health treatments
29. Using CBC for Prediction of Outcome
Cycle 1 (n=391) predicts Cycle 2 (n=397) including dead
Stepwise model accuracy 68.8%
Predicted Resilient pigs in Cycle 2
Actual Resilient 40% versus 29% in Predicted Susceptible
Grow 25g/day faster (all included)
Ave treatment rate 0.5x less
Mortality 0% versus 13%
Work in progress – results highly dependent on assumptions
and classification of resilient pigs in the training set.
30. Blood Transcriptome and Resilience
Differentially expressed
genes identified in three
different environments
“predicting outcome”
NC1
Genome dx.doi.org/10.1139/gen-2017-0074
31. • A natural challenge model for characterization of
disease resilience in pigs has been successfully
established
Conclusions 2
• Initial CBC shows initial promise as a predictor of
phenotypic resilience.
• Test different predictors with MSE of FI.
• Genetic analysis, GWAS (660k)……………….
32. Next?
• Complete data collection (3,300 from 2,000 today)
• Integrate analyses
• Explore blood transcriptome (3’RNAseq), metabolome
and proteome on 960 samples (14 batches) (USDA NIFA)
• Explore infectivity (Andrea Wilson, RI)
• The effect of environmental enrichment on the immune
response and measures of disease resilience and welfare
in pigs. (Yolande Seddon, U of SK)
• Other opportunities – e.g. pen-side diagnostics
Figure 1. Schematic overview of phenomics to develop genetic and phenotypic predictors of resilience. Red underlined text indicates phenomic data and information that will be generated in the proposed work, building on phenotypic and genotypic data that will be generated as part of the existing Genome Alberta and Genome Canada project, as well as in the FAANG project, in which a total of 3,500 healthy weaner pigs are first evaluated in a quarantine nursery and then entered in a natural challenge nursery-grow-finish research facility. Project data, analyses and results will both utilize and contribute to the FAANG project.
Data collected only on a limited number of case-control animal
Resilience, indicator, and intermediate –omics traits and their interrelationships